WOC-3B

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameWOC-3B
Drug Alias Namesomatostatin agonist (Ohio)WOC-3B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 1 antagonistsSomatostatin receptor 2 antagonists
TargetsSomatostatin receptor 1Somatostatin receptor 2
Therapy Area/IndicationsDiarrheaHypersensitivity, Immediate
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Ohio State University
Active IndicationsN/A
Inactive IndicationsDiarrheaHypersensitivity, Immediate

Other Information

ATC CodeN/A
Related LinksN/A